The Strategic Foundation
The most critical decisions in a device's journey happen before development begins. The "Intended Use" statement dictates the device's classification, which in turn determines the entire regulatory pathway, evidence requirements, cost, and time to market. Explore below how this single decision creates branching paths in the US and EU.
🇺🇸 United States (FDA)
Risk-Based Classification
🇪🇺 European Union (MDR)
Rule-Based Classification
Select a classification to see details
Click on any of the device classes above to learn about its typical regulatory pathway and clinical data requirements.
The Trial Journey: An End-to-End View
A clinical trial is a highly structured, multi-phase project. From initial design to final report, each step is meticulously planned and executed to ensure patient safety and data integrity. Click on each step of the timeline below to explore the key activities, roles, and outputs for that phase.
Plan
Approve
Execute
Analyze
Report
Key Activities
Primary Outputs
Key Players & Critical Documents
A clinical trial is a team sport involving many internal and external stakeholders, each with specific responsibilities. It also generates a series of critical documents that form the official record. Use the filters to explore.
US vs. EU: A Tale of Two Systems
While both the US FDA and EU MDR prioritize patient safety, their philosophies and processes have crucial differences that impact strategy, timelines, and costs. Select a topic to compare.
